<?xml version="1.0" encoding="UTF-8"?>
<p class="p">IBD, specifically Crohn’s disease (CD) and ulcerative colitis (UC), are relapsing and remitting inflammatory diseases of the GI tract without a clear etiology. The symptoms include abdominal pain, diarrhea, weight loss, ulceration, perforation, and bowel obstruction. Although the all picture of the pathogenesis of IBD remains unclear, aberrations in genetics, imbalances in the gut microbiome, dietary and lifestyle factors such as cigarette smoking, medications, and environmental triggers (i.e., geographical location and social status) are all believed to play a role in the disease’s development (
 <xref ref-type="fig" rid="marinedrugs-17-00374-f004" class="xref">Figure 4</xref>).
</p>
